000 01510 a2200397 4500
005 20250517163432.0
264 0 _c20190708
008 201907s 0 0 eng d
022 _a1098-8785
024 7 _a10.1055/s-0037-1604195
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStone, Rebecca H
245 0 0 _aPrevention of Preterm Labor with 17α-Hydroxyprogesterone (17OHP) Caproate: A Comparison of Adverse Drug Reaction Rates between Compounded and Commercial Formulations.
_h[electronic resource]
260 _bAmerican journal of perinatology
_c12 2017
300 _a1436-1441 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _a17 alpha-Hydroxyprogesterone Caproate
650 0 4 _aAdult
650 0 4 _aDrug Compounding
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xepidemiology
650 0 4 _aFemale
650 0 4 _aGestational Age
650 0 4 _aHumans
650 0 4 _aHydroxyprogesterones
_xadverse effects
650 0 4 _aPregnancy
650 0 4 _aPremature Birth
_xprevention & control
650 0 4 _aRetrospective Studies
650 0 4 _aYoung Adult
650 0 4 _aAssessment of Medication Adherence
700 1 _aBobowski, Christina
700 1 _aMilikhiker, Nataliya
700 1 _aAnguiano, Rebekah H
700 1 _aMastrogiannis, Dimitrios
773 0 _tAmerican journal of perinatology
_gvol. 34
_gno. 14
_gp. 1436-1441
856 4 0 _uhttps://doi.org/10.1055/s-0037-1604195
_zAvailable from publisher's website
999 _c27364915
_d27364915